Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18


Is Mania the Hypertension of the Mood? Discussion of A Hypothesis.

Rihmer Z, Gonda X, Döme P.

Curr Neuropharmacol. 2017 Apr;15(3):424-433. doi: 10.2174/1570159X14666160902145635. Review.


A neuroplastic deafferentation hypothesis for bipolar disorder.

Rogers J, Mirams J, Patel R.

Med Hypotheses. 2015 Dec;85(6):858-62. doi: 10.1016/j.mehy.2015.09.023. Epub 2015 Sep 28.


Animal models of bipolar mania: The past, present and future.

Logan RW, McClung CA.

Neuroscience. 2016 May 3;321:163-88. doi: 10.1016/j.neuroscience.2015.08.041. Epub 2015 Aug 24. Review.


Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.

Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P, Sani G.

Curr Neuropharmacol. 2015 Jan;13(1):101-21. doi: 10.2174/1570159X13666141210222725. Review.


Cognitive judgment bias in the psychostimulant-induced model of mania in rats.

Rygula R, Szczech E, Kregiel J, Golebiowska J, Kubik J, Popik P.

Psychopharmacology (Berl). 2015 Feb;232(3):651-60. doi: 10.1007/s00213-014-3707-y. Epub 2014 Aug 14.


The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

van Enkhuizen J, Janowsky DS, Olivier B, Minassian A, Perry W, Young JW, Geyer MA.

Eur J Pharmacol. 2015 Apr 15;753:114-26. doi: 10.1016/j.ejphar.2014.05.063. Epub 2014 Aug 5. Review.


Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report.

Hariram J, Jegan Y.

Ther Adv Psychopharmacol. 2013 Aug;3(4):251-4. doi: 10.1177/2045125313477103.


A case of chloroquine-induced recurrent mania.

Bhatia MS, Jhanjee A, Oberoi A.

Prim Care Companion CNS Disord. 2012;14(3). pii: PCC.11l01302. doi: 10.4088/PCC.11l01302. Epub 2012 May 17. No abstract available.


Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.

Ramadan E, Basselin M, Taha AY, Cheon Y, Chang L, Chen M, Rapoport SI.

Neuropharmacology. 2011 Dec;61(8):1256-64. doi: 10.1016/j.neuropharm.2011.07.025. Epub 2011 Aug 3.


Predictive animal models of mania: hits, misses and future directions.

Young JW, Henry BL, Geyer MA.

Br J Pharmacol. 2011 Oct;164(4):1263-84. doi: 10.1111/j.1476-5381.2011.01318.x. Review.


The diagnostic dilemma of pathological appearance and performance enhancing drug use.

Hildebrandt T, Lai JK, Langenbucher JW, Schneider M, Yehuda R, Pfaff DW.

Drug Alcohol Depend. 2011 Mar 1;114(1):1-11. doi: 10.1016/j.drugalcdep.2010.09.018. Epub 2010 Nov 5. Review.


Identification and treatment of a pineal region tumor in an adolescent with prodromal psychotic symptoms.

Mittal VA, Karlsgodt K, Zinberg J, Cannon TD, Bearden CE.

Am J Psychiatry. 2010 Sep;167(9):1033-7. doi: 10.1176/appi.ajp.2010.09071043.


Bipolar disorder and mechanisms of action of mood stabilizers.

Rapoport SI, Basselin M, Kim HW, Rao JS.

Brain Res Rev. 2009 Oct;61(2):185-209. doi: 10.1016/j.brainresrev.2009.06.003. Epub 2009 Jun 23. Review.


Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.

Basselin M, Chang L, Chen M, Bell JM, Rapoport SI.

Neurochem Res. 2008 Nov;33(11):2229-40. doi: 10.1007/s11064-008-9700-2. Epub 2008 May 7.


Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.

Basselin M, Chang L, Chen M, Bell JM, Rapoport SI.

Neurochem Res. 2008 Jul;33(7):1373-83. doi: 10.1007/s11064-008-9595-y. Epub 2008 Feb 27.


The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.

Engel SR, Creson TK, Hao Y, Shen Y, Maeng S, Nekrasova T, Landreth GE, Manji HK, Chen G.

Mol Psychiatry. 2009 Apr;14(4):448-61. doi: 10.1038/ Epub 2008 Jan 29.


Frontotemporal and dopaminergic control of idea generation and creative drive.

Flaherty AW.

J Comp Neurol. 2005 Dec 5;493(1):147-53. Review.

Supplemental Content

Support Center